India  /  Published 04.03.23

CDC probe links India cough syrup

The report further said medications for export might be subject to less rigorous regulatory standards than those for domestic use...
By PTI in New Delhi

India  /  Published 28.02.23

Court orders jail for two Maiden executives

The two were also fined Rs 100,000 each for exporting the medicine, Ranitidine Tablets B.P (Mantek-150), to Vietnam...
By Reuters in New Delhi

India  /  Published 24.01.23

WHO alert on drug quality

Global health agency has since October issued three global alerts cautioning against cough syrups contaminated with toxic chemicals called diethylene glycol and ethylene glycol...
By G.S. Mudur in New Delhi

India  /  Published 29.12.22

BJP, Congress spar over cough syrup

The death of children in Gambia had nothing to do with consumption of cough syrup made in India. That has been clarified by the Gambian authorities and DCGI, both: Amit Malviya...
By PTI in New Delhi

India  /  Published 29.12.22

Indian syrup tied to kid deaths in Uzbekistan

Marion Biotech officials were not immediately available on Wednesday to respond to Uzbek ministry’s claims...
By G.S. Mudur in New Delhi


India  /  Published 27.12.22

Gambia deaths: India inspects drug factories

Joint inspections are being conducted all over the country as per standard operating procedures, says the Ministry of Health and Family Welfare ...
By Reuters in Mumbai

India  /  Published 25.12.22

Gambia: WHO firm on syrup

Contaminants ‘are dangerous and should not be in any medicine ever’, World Health Organisation spokesperson tells The Telegraph...
By G.S. Mudur in New Delhi

India  /  Published 18.10.22

Gambia sceptics face suit threat

Health activist Dinesh Thakur and lawyer T. Prashant Reddy had said that the central regulator needed to share responsibility with the state regulator concerned for the export of the syrups...
By G.S. Mudur in New Delhi

India  /  Published 15.10.22

Cough syrups: 'Information inadequate so far'

The committee will recommend further course of action to the Drugs Controller General of India after examining and analysing the adverse event reports...
By PTI in New Delhi

Opinion  /  Published 13.10.22

Costly error: Export of spurious drugs

Diplomatic gains over the years will be lost if the Indian govt does not undertake corrective action in pharma sector...
By The Editorial Board


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.